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Abstract  
 
     Many Chinese Herbal medicines (CHMs) and their components have been reported to enhance immunity. In this 
study, the capacity for the Chinese herbal medicine, oral administration Sijunzi Decoction (SJZD) in stimulating Newcastle 
disease virus(NDV) immunity in chickens was examined. Serum was sampled on days 20，30，40，50 and 60 and tissues were 
collected on days 20, 40 and 60, respectively. The immune responses were determined by means of hemagglutination 
inhibition test, immunohistochemistry examination and semi-quantitative RT–PCR. The results showed that SJZD could 
increase the antibody titers and the area coefficient of IgA secreting cells, promote the expression of IL-2 mRNA in the whole 
immune period and IFN-γ mRNA was increased in the initial stage. The SJZD used was safe with no adverse effects on 
chicken weight or survival, providing evidence for the use of SJZD as an oral adjuvant. 
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Introduction 
 
     Newcastle disease (ND) is a highly contagious and widespread disease which causes severe economic losses in 
domestic poultry, especially in chickens (Liu et al.,2003; Sinkovics and Horvath, 2000). Vaccination remains the most 
cost-effective biomedical approach for controlling the disease. Many researchers have found that oral immunization with 
attenuated Newcastle-disease vaccine could induce host immunity, and improve mucosal and systemic immune responses 
(Zuercher et al., 2006; Zhang et al., 2008; Zhang et al., 2007). However, oral vaccination needs more and repeated antigen 
doses to achieve the protective immune response level, because of degradation of the antigen by gastric acid and proteases 
present in the gastrointestinal tract (Hoshi et al., 1998; Holmgren et al., 1992, 2003). Therefore, it is necessary to develop 
strategies to induce mucosal immune responses effectively by using a small amount of antigen. An important factor which 
influences the effectiveness of mucosal immunization is the nature and efficacy of the adjuvant (Hoshi et al, 1998). A number 
of studies have demonstrated that the combinative application of vaccine with adjuvants or immunopotentiators could 
improve the efficacy of oral vaccination. Unfortunately, strong adjuvant activity is often correlated with undesirable 
side-effects, such as local stimulation, tissue damage and so on (Sun et al., 2009). Therefore, it is very important to develop 
immunopotentiators with high efficacy, low toxicity, and extensive availability. 
   Many Chinese herbal medicines (CHMs) and their components have been reported to enhance immunity. Combined 
use of vaccines with Chinese herbal medicines is emerging as one of the innovative approaches in adjuvant development. 
Particular advantages offered by herbal adjuvants in inducing cellular and humoral immunity are extremely safe, tolerable, 
ease to manufacture. Thus, the herbal adjuvants have enormous potentials for use in vaccinations against both pathogens and 
cancer (Petrovsky, 2006) .  
   Sijunzi decoction has been used in China since Song dynasty (960-1279 AD) as a tonic. It ranks at the first top of 
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tonifying formulas. The formula is traditionally believed to be immunoenhancer (Zhang Ed.,1990). There have been an 
increasing amount of papers on herbal immunopotentiators (Wang et al., 2006b). In the present study, the capacity for the 
Chinese herbal medicine sijunzi decoction (SJZD) in stimulating immunity against Newcastle disease virus (NDV) following 
oral administration to chickens was examined. We investigated the adjuvant effects of the Sijunzi Decoction (SJZD) with 
respect to mucosal and systemic immune responses. Additionally, The dose dependent responses of immune enhancement by 
SJZD were also evaluated. 
 
 
Materials and Methods 
Preparation of sijunzi decoction(SJZD) 
 
  The formula Sijunzi decoction consists of 4 crude herbs, i.e., Panax ginseng, Poria cocos, Atractylodes macrocephala 
and Glycyrrhiza uralensis at a ratio of 2:2:2:1. The herbs were purchased from a local Herbal Shop Tongrentang Herbal 
Company Ltd(Baoding, China) and authenticated by the Hebei provincial Bureau of herbal medicine. The herbs were boiled 
in water 10 times the weight of the herbs for 0.5 h and then the aqueous extract separated by filtration. The remaining herbs 
were decocted again for another 0.5 h as in the above. The two liquid parts were mixed and heated (50–60℃) through rotary 
evaporation to reduce the water content, and concentrated into 1:1 concentration decoction (Lenon et al.,2007), i.e., 1 ml of 
the concentrated extract was equivalent to 1g of the raw herb. Then, the herbal preparations were sterilized in sealed plastic 
bottles and diluted in distilled water to the low (0.125 g/ml), medium(0.25 g/ml), high(0.5 g/ml) dosages on the day of use. 
 
Reagents 
 
   SP-9002 HistostainTM-Plus kits (Zhongshan Biotech Co., Ltd. Beijing, China) consists of Bloking solution, 3% H2O2, 
Biotin-goat anti-mouse IgG, Streptavidin peroxidase (S-A/HRP). Mouse anti-chicken IgA (Southern Biotech, Inc, USA), 
Diaminobenzidine (DAB, Sigma, USA). Moloney murine leukemia virus (M-MLV) reverse transcriptase, 5x RT buffer, Taq 
DNA polymerase and Oligo d(T)18 primer, dNTPs, were products from Tiangen Biotech (Beijing, China).  
 
Vaccine 
 
   The attenuated Newcastle-disease vaccine virus (La Sota strain, catalog no. 080519) was offered by Ruipu Biotech 
(Baoding, China) and diluted with sterilized phosphate-buffered saline (PBS, pH 7.4). 
 
Animals 
 
   One-day-old white Leghorn chickens (male), purchased from Fanzhuang Poultry Farm, were housed in wire cages (60 
cm×100 cm). Chickens were fed with the commercial starter diet, provided by the feed factory of Fangtian in Baoding city. 
Feed and water were supplied ad libitum. All animal experiments were performed in accordance with the guide for the Care 
and Use of Laboratory Animals published by the Agricultural University of Hebei. 
 
Experimental design 
 
   One hundred and fifty chickens were randomly divided into five groups. Each chicken in herb groups A, B and C 
received different dosages of herbal treatments on day 12 as shown in Table 1 consecutively for 7 days. Group D was kept as 
non-herbal-non-vaccine control. Birds in Group E were non-herbal controls, receiving ND vaccine only. Birds in groups D 
and E were given equivalent amount of normal saline as in groups A, B, and C. On day 14, their average titer of maternal 
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antibody was 3.8 log2 and the average bodyweight was 110±8g. Birds in groups A, B, C and E were orally vaccinated with 
0.5ml (106EID50 per chicken) of attenuated Newcastle-disease vaccine virus, while group D received 0.5ml normal saline. 
The chickens of all the above-mentioned groups were vaccinated again on day 35 with the same dosages and in the same 
manners.  
 
Sample collection 
 
   On Days 20 (D20), 30 (D30), 40 (D40), 50 (D50) and 60 (D60), six chickens were sampled randomly from each group 
for determination of serum antibody. Blood samples (1.0 ml per chicken) were drawn into Eppendorf tubes from the main 
brachial vein of chickens and allowed to clot at 37 ◦C for 1 h prior to serum collection. Serum was separated by centrifugation 
and stored at−20 ◦C for use. On Days 20 (D20), 40 (D40), and 60 (D60), tissue samples of five chickens were taken . The tissue 
samples of jejunum (three pieces of each tissue, 1 cm away from each other) were collected immediately, frozen in liquid 
nitrogen and then stored at −80 °C until RNA extraction and other analysis. Other tissue samples of duodenum and jejunum 
(at least three pieces, 1 cm away from each other) and Peyer’s patch were fixed in Bouin’s liquid. 
  
  Table 1: Animal treatment in different groups  
Group Exposure Group N Immunogen dose 
ml/chicken  
Dose of SJZD（g/ml） 
A SJZD(L)+ND 30 0.5 0.125 
B SJZD(M)+ND 30 0.5 0.25 
C SJZD(H)+ND 30 0.5 0.5 
D Control 30 --- --- 
E ND 30 0.5 --- 
Notes: SJZD(L), Low dose of SJZD; SJZD(M):Medium dose of SJZD; SJZD(H): High dose of SJZD; ND,Newcastle Disease 
vaccination. N, Number of chickens in each experimental group. 
 
Table 2: Oligonucleotide primer sets used for semi-quantitative RT–PCR 
Genes Accession No. Primer sets Primer Sequences Product Size (bp) 
β-actin L08165 F CATCTATCGTGGGTCGC 547 
  R CTCCTTGATGTCACGCAC  
IL-2 AF017645 F TATCGAAAAGAACCTCAAG 245 
  R CCAGAATGGACAGCAGA  
IFN-γ NM_205149 F GCTGACGGTGGACCTATT 240 
  R CAAGTCGTTCATCGGGAG  
 
 
Measurement of ND Antibody   
 
   The antibody response to NDV-virus was determined by means of haemagglutination inhibition (HI). Briefly, 
two-fold serial dilution of serum, after inactivated at 56 °C for 30 min, were made in a 96-well, V-shaped bottom microtiter 
plate containing 50 μl of 0.9% NaCl in all wells and then 50μl of NDV antigen (four HA units) was added into all the wells 
except for the last row which served as the controls. Serum dilutions ranged from 1:2 to 1:2048. The antigen serum mixture 
was incubated for 10 min at 37 °C. Then 50 μl of a 1% rooster erythrocytes suspension was added to each well and 
re-incubated for 30min. A positive serum, a negative serum, erythrocytes, and antigens were also included as controls. The 
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highest dilution of serum causing complete inhibition was considered the endpoint. The geometric mean titer was expressed 
as reciprocal log2 values of the highest dilution that displayed HI. 
 
Immunohistochemical examination for IgA secreting cells 
 
   The fixed samples duodenum and jejunum were embedded in paraffin and serial sections of 5 μm were prepared. The 
sections were deparaphinized and hydrated, then the endogenous peroxidase activity was neutralized by 3% H2O2 for 30 min. 
The sections were treated with 5% normal goat serum in PBS for 30min to block non-specific binding and then stained with 
mouse anti-chicken IgA(1:200) at 4°C over night. The sections were rinsed three times with PBS for 5min each and then 
incubated with goat anti-mouse IgG at 37°C for 40 min. The sections were rinsed three times with PBS for 5min each, 
followed by incubation with S-A/HRP for 35 min at 37°C. After the sections were rinsed three times in PBS, the reactions 
were made visible with metal-enhanced diaminobenzidine (DAB). 
 
Detection of Cytokine mRNA by Semi-Quantitative RT–PCR 
 
   The mRNA expression of the cytokines IL-2 and INF-γ were determined with a reverse transcriptional polymerase 
chain reaction (RT-PCR). The housekeeping gene, β-actin was used as an internal control. Total RNA was extracted from 
jejunum according to the RNA Simple Total RNA Kit’s instruction and quantified by determining the optical density at 260 
nm. RNA was reverse transcribed into cDNA with Oligo d(T)18. The RT reaction mixture contained 20 μl: 1 μl of Oligo 
d(T)18 primer, 2 μl of 2.5 mM stock of dNTPs and 11.5 μl of DNAse-treated RNA in DEPC water were denatured at 70°C for 
5 min and immediately chilled on ice for 3 min. The following reagents were added: 4 μl of 5x RT buffer, and 0.5 μl 
Ribonuclease inhibitor, 1 μl of 50 μnits /μl of TranScript RT. The contents were mixed gently and briefly centrifuged 
followed by incubation at 42°C for 50 min. Finally, the reaction was stopped by heating at 95 °C for 5min and all cDNA 
samples were stored at −80 °C prior to amplification. The resulting cDNA was subjected to polymerase chain reaction (PCR) 
with respective primers designed from the sequences of two cytokines. Amplification was carried out in a total volume of 25 
μl containing 2 μl (10 μM) of each cytokine- specific primers (Table 2), 2.5 μl 10× PCR buffer,2 μl dNTP, 2 μl cDNA and 
0.5 μl Taq DNA polymerase. The PCR condition of IL-2 mRNA: at 94 °C for 4min (denaturation 94 °C for 50 s; annealing 
54 °C for 50 s; polymerization 72 °C for 50 s), 31cycles, the reaction was extended at 72 °C for 10min; the PCR condition of 
IFN-γ mRNA: at 94 °C for 4min (denaturation 94 °C for 50 s; annealing 56 °Cfor 50 s; polymerization72 °C for 50 s), 35 
cycles, the reaction was extended at 72 °C for 10min. Different controls were set to monitor the possible contaminations of 
genomic and environment DNA both at the stage of RT and PCR. The PCR products were electrophoresed with 1% agarose 
gel and stained with ethidium bromide. The quantity of PCR products was analyzed by densitometer. The relative value of 
IL-2 or IFN-γ mRNA= (the value of IL-2 or IFN-γ mRNA)/(the value of β-actin), which can mean the high or low of 
expression of IL-2 or IFN-γ mRNA. All experiments were carried out in triplicate. 
 
Safety tests 
 
   For assessment of potential adverse effects of SJZD, the weight of ten chickens each group was monitored on days 
12 and 19. Any weight change in SJZD treated chickens was compared to group control to determine whether any deviation 
from normal growth rates occurred during the administration of SJZD. Additionally, Survival rates were also undertaken as 
an indicator of herbal toxicity relative to control group.  
 
Statistical analysis 
 
    The areas of IgA secreting cells in 10 different microscope fields of well-oriented, intact intestinal villi in each 
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tissue (total 5×5 sections) was measured by Scion Image. The data were calculated by the area coefficient of IgA secreting 
cell. The area coefficient of IgA secreting cell = the area of IgA secreting cells (µm2)/the area of the selected tissue (µm2). All 
the data were expressed as mean±S.D. and analysed by one-way ANOVA using SPSS 13.0. The treatment effects were 
considered significant if the p-value was at or below 0.05. 
 
Results 
The dynamic changes of serum antibody titer 
 
   Dynamic changes of serum HI antibody titers were listed in Table 3. In general, the antibody titers of all SJZD 
treated groups at each time point were higher than that of Group E. The antibody titers in group B and group C were 
significantly higher than those of group E (p<0.01) on days 40 and 60. Meanwhile, the average antibody titers were increased 
about two titers. On days 30 and 50 the antibody titers of group B and group C were significantly higher than those of group 
E (p<0.05). There was no significant difference in the antibody titers at most time points between group A and group E. 
 
              Table 3: ND antibody titer in different experimental groups 
Group 20d 30d 40d 50d 60d 
A 5.3±0.71b 7.1±0.89B 7.3±1.14b 7.4±0.54B 6.2±0.45C 
B 5.8±0.83b 7.8±0.41Bb 8.2±0.83Ca 8.1±1.14Ba 7.2±0.83Bb 
C 5.6±1.14b 7.9±0.75Bb 8.6±0.89Ca 7.8±0.83Ba 8.1±0.71Bb 
D  4.0±0.71a 3.7±0.44A 3.3±0.55A 2.8±0.50A 2.0±0.64A 
E 5.2±1.30 6.7±0.81Ba  6.4±0.54B  6.5±1.14Bb 5.8±1.10Ca  
Note: Values in the same column with different letters are significantly different, lowercase means P < 0.05, majuscule means P < 
0.01. 
Table 4: The influence of SiJunZi Decoction on the IgA secreting cells in the intestine of chicken 
Tissues Day A B C D E 
 20 1.59±0.15Aac 1.49±0.21ac 1.52±0.13Ac 1.13±.093Bbc 1.23±0.11b 
Duodenum 40 4.42±0.17A 4.34±0.84A 4.44±0.28A 2.57±0.13B 3.01±0.13B 
 60 6.56±0.50A 7.78±1.45A 7.51±1.23A 4.01±0.56B 4.79±0.56B 
 20 1.01±0.23 1.19±0.16a 1.19±0.21a 0.83±0.16b 1.02±0.95 
Jejunum 40 2.22±0.33a 2.29±0.14a 2.31±0.11a 1.40±.046b 1.82±0.18c 
 60 4.15±0.33A 4.19±0.15A 4.16±0.12A 3.10±0.16B 3.99±0.12A 
 20 0.82±0.21 0.77±0.19 0.96±0.16a 0.52±0.16b 0.73±0.23 
Peyer’s Patch 40 1.78±0.17ac 1.78±0.23ac 1.87±0.18a 1.23±0.11b 1.52±0.27bc 
 60 2.69±0.64 3.18±1.08ab 3.49±0.17Aa 1.92±0.14Bc 2.26±0.42bc 
Note: Values in the same column with different letters are significantly different, lowercase means P < 0.05, majuscule 
means P < 0.01. 
Table 5: The weights of chickens in different experimental groups during the administration of SJZD 
Group Grams on day 12 Grams on day 19 PT p-Value 
A 111.0±3.61 177.1±5.57 NS 
B 109.6±4.73 182.8±12.53 ns 
C 110.6±5.81 177.6±11.68 ns 
D 110.3±3.51 176.3±16.52 ns 
E 111.1±3.91 169.7±10.59  ns 
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      PT: Post-SJZD treatment. NS: Not significant (compared to the relevant treatment or control groups) 
 
 
The area coefficient changes of IgA secreting cells in duodenum, jejunum and Peyer’s Patch. 
 
    In each fragment of intestine samples, IgA secreting cells were recognized as lymphocytes by their characteristic 
morphology: rounded, with a nucleus surrounded by a ring of yellow-brown cytoplasma. These cells were present in the 
lamina propria of villi in the duodenum and jejunum surrounding the glands (Figure 1 A-D). In the duodenum, the area 
coefficient of IgA secreting cells of group A and group C was increased significantly than that of group E (p<0.05) on day 20. 
The area coefficients of all SJZD treated groups were increased significantly than that of group E (p<0.01) on days 40 and 60. 
On day 40, the area coefficient of IgA secreting cells in the jejunum of all SJZD treated groups was increased significantly 
than that of group E (p<0.05). The area coefficient of IgA secreting cells in the Peyer’s Patch, only higher in group A than 
that of group E (p<0.01) on days 40 and 60 (Table 4). 
 
The IL-2 and IFN-γ mRNA level changes in jejunum 
 
   Transcription of IL-2 mRNA and IFN-γ mRNA in the jejunum was evaluated on days 20, 40 and 60 by RT-PCR. 
Compared with group E, high levels of IL-2 mRNA responses were detected in all vaccination groups with Sijunzi Decoction 
treatment. The IL-2 mRNA levels of all SJZD treated groups were increased significantly than that of Group E (p<0.01 and 
p<0.05) on days 20 and 60 respectively. The IL-2 mRNA levels of group A and group B were increased significantly than that 
of group E (p<0.05) on day 40. In addition, SJZD increased IFN-γ expression in the group B (P<0.05) and significantly 
increased IFN-γ mRNA in the group C (P<0.01) on day 20. At this time point SJZD increased IFN-γ expression in a 
dose-dependent manner in all groups. The mRNA level of IFN-γ in group B was significantly higher than that of group E 
(p<0.05) on day 40, but on 60 days old, The expression of IFN-γ mRNA was decreased and became similar to the group D 
and group E (Figures 2 and 3). 
 
Safety tests 
 
   All chickens used for testing the safety of SJZD remained clinically healthy after the administration of SJZD. There 
was no difference observed in the mean weights of chickens treated with SJZD, the mean weight of the high dose SJZD 
group being 110.6 at the beginning and 177.6 g at the end of the administration, respectively. By comparison, the mean body 
weight recorded for the group D was 110.3 and 176.3 g, respectively (Table 5). Four chickens did not survive during the 
entire period of the experiments, equally distributed into every group except group B, giving an overall survival rate of 97.3% 
(Figure 4). It is indicated that there was no significant SJZD treatment effect on chicken survival rate. Therefore, these results 
suggest it is safe to use SJZD in chickens in this study. 
 
Discussion 
 
   The immune response to NDV has been studied extensively. A number of NDV-adjuvant preparations have been 
investigated in animals (Zhang et al., 2007; Guo et al., 2009) and the specificity of the immune response is an integral 
parameter for assessment of novel adjuvant preparations (Marciani, 2003). Merz et al. (1981) reported that both humoral and 
cellular immune responses played important roles in the host’s defense against NDV infection. The herbal formula Sijunzi 
decoction has been used in ancient China as a tonic and as an immunoenhancer in modern times (Zhang ed., 1990). Therefore, 
we studied the immunopotentiating effects of the formula. For humoral immune responses, serum antibody titer and IgA 
secreting cells were investigated. For cellular immune responses, IFN-γ mRNA and IL-2 mRNA were studied. 
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Previous studies have shown that the HI antibody is directly effective against NDV in chickens (Maas et al., 2003; Roy et al., 
1999) and therefore antibody titer responses have been used as indicators of humoral immune status of birds (Kong et al.,   
 
Figure1: A. IgA secreting cells in duodenum. B. IgA secreting cells arround the intestinal glands. C. IgA secreting cells in 
jejunum. D. IgA secreting cells in Peyer’s Patch. The IgA secreting cells were pointed by the arrows. Scale 
bar=30μm. 
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Figure 2: The RT-PCR electrophoiesis photo (a) and analysis results (b) of SiJunZi Decoction on the level of IL-2 mRNA 
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expression.  M: 2000bp ladder of DNA markers; Lane 1: The samples of High(0.5 g/ml); Lane 2:Medium(0.25 
g/ml); Lane 3: Low(0.125 g/ml) dosages of Sijunzi Decoction; Lane 4: ND; Lane 5: the control. 
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Figure 3: The RT-PCR electrophoiesis photo (a) and analysis results (b) of SiJunZi Decoction on the level of IFN-γ mRNA 
expression.  M: 2000bp ladder of DNA markers; Lane 1: The samples of High(0.5 g/ml); Lane 2:Medium(0.25 
g/ml); Lane 3: Low(0.125 g/ml) dosages of Sijunzi Decoction; Lane 4: ND; Lane 5: the control. 
 
 
 
2004). In this experiment, the anti-ND virus HI antibody titers in most treatment groups were higher than that of the control 
group at nearly all time points. From day 30 to day 40, the titers in each group reached higher levels. In all SJZD treated 
groups, the titers reached 7.8 to 8.6 log2, whereas in the control group, the titers reached 6.4 to 6.7 log2. On day 60, the titer 
in the control group dropped to 5.8 log2. Whereas in SJZD treated groups, the titers dropped to 6.2 and 8.1 log2. These 
findings indicate that at medium and high dosages SJZD could promote specific antibody production earlier and maintain it 
longer, and thus improve the immune effect of the vaccine. 
   The IgA secreting cells in the laminal propria tissue of intestine are the important effect molecules in protecting 
mucosal surfaces. Now the changes of IgA secreting cells in intestine are one of the standards to estimate intestine mucosal 
immunity (Zhang et al., 2007). The results of the experiment showed that the areas of IgA secreting cells of all SJZD treated 
groups were higher than that of the ND vaccine-only Group in the whole immune period. Consequently, it can be concluded 
that SJZD could stimulate the formation of IgA secreting cells in the local mucosal and enhance the local immune response of 
the small intestine. The immunomodulatory properties of adjuvant are well-documented. Many substances have been shown 
to act as vaccine adjuvants (Singh and O'Hagan, 2003; Nugent et al., 1998). Furthermore, the majority of which have only 
been used in admixture with antigen. Most significantly in this study, the antigen (ND) and adjuvant (SJZD) were not 
administered in admixture but at separate times according to a ‘Two-Time Immunization Method (TTIM)’ developed in our 
laboratory. The ability of oral SJZD to enhance mucosal immunized antigen suggests an alternative mode of action as 
conventional adjuvants are thought to rely on physicochemical interactions including the maintenance of antigenic 
conformation and depot related effects that stimulate immune activationn (Yang et al., 2005; Schijns and Tangerås, 2005). 
   In addition to antibodies, cell-mediated immunity also plays an important role in immunity against virulent ND virus 
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(Zhang et al., 2008). In recent years, numerous studies had demonstrated that a lot of Chinese herbal medicine could improve 
the expression of cytokines so as to enhance the immunity (Yang et al., 2008; Chu et al., 2005; Wang et al.., 2006a). However, 
these studies were focused on the changes of cytokine mRNA transcription of peripheral lymphocytes and monocytes after 
stimulation in the short term. In our experiments, total RNA was extracted from jejunum directly, then changes of IL-2 
mRNA and IFN-γ mRNA was detected. The mRNA  expression has become more sensitive and more directly in reflecting 
local immune responses following oral SJZD treatment of NDV-immunized chickens. High levels of IL-2 mRNA responses 
were detected in all treated groups. Additionally, The change of IFN-γ mRNA was detected in initial stage. Furthermore, the 
results increased linearly when the level of SJZD increased. But in late immune stage, the change of IFN-γ mRNA was not 
detected. We assumed that the expression of IFN-γ mRNA was higher in initial immune stage, and then the mRNA was 
rapidly translated into protein. So the IFN-γ mRNA transcription was decreased in the late stage of immunization. 
   At present, there were only a small number of reports about the application of Chinese herbal medicine as a mucosal 
adjuvant to improve the immunity. This study reports, for the first time to our knowledge, the immunostimulatory capacity of 
the complete SJZD preparation as a mucosal adjuvant. SJZD contains extracts from multiple herb extracts that exhibit 
immunostimulatory and may partly explain this observed SJZD effect. Many studies have demonstrated application of SJZD 
on the base of enteric nutritional therapy can lessen the degree of post- operational stress and inflammatory response, and 
enhance the immune function of patients (Cai et al., 2008; Wu and Xuan, 2007; Liang et al., 2005). Rivera et al.( 2003a; 
2003b) reported that the synergistic effect of aluminium hydroxide and ginseng was observed. Poria cocos was reported to 
stimulate a number of immune response parameters including NO production in macrophage in vitro and in vivo as well as 
IFN-γ and TNF-α(Lee and Jeon, 2003; Chen and Chang, 2004). Glycyrrhiza uralensis saponins (GLS) isolated from 
Glycyrrhiza uralensis were reported to show a slight haemolytic effect and to enhance significantly the specific antibody and 
cellular response against OVA in mice (Sun and Pan, 2006). In this study, the induction of immune responses in both systemic 
and mucosal immunity indicates that the combination of bioactive vaccine within SJZD acts synergistically to produce an 
overall stimulatory effect on immune cell activation. 
   In conclusion, our results showed that SJZD had effects on enhancing humoral and cellular immune responses to 
NDV-immunized chickens. Taken together with its natural origin, without lethal toxicity to humans and animals, and 
longstanding use as folk medicines, SJZD may be useful as a novel mucosal adjuvant that improves the effectiveness of 
chicken vaccines or provides optimal protection against common infections in chickens. 
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